デフォルト表紙
市場調査レポート
商品コード
1465966

造影剤市場:タイプ別、手技別、投与経路別、用途別、エンドユーザー別、適応疾患別-2024~2030年世界予測

Contrast Media Market by Type, Procedure, Route Of Administration, Application, End-user, Disease Indication - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
造影剤市場:タイプ別、手技別、投与経路別、用途別、エンドユーザー別、適応疾患別-2024~2030年世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

造影剤市場規模は、2023年に36億7,000万米ドルと推定され、2024年には40億2,000万米ドルに達し、CAGR 9.75%で2030年には70億4,000万米ドルに達すると予測されています。

造影剤は、体内の組織、臓器、その他の構造の可視性を高めるために医療用画像処理で使用される物質です。コンピュータ断層撮影(CT)、X線、超音波スキャン、磁気共鳴画像法(MRI)などの画像処理装置が、身体とどのように相互作用するかを変えることによって機能します。これらの薬剤は、得られる画像のコントラストを向上させることにより、試験部位の鮮明な画像を提供し、様々な疾患の正確な診断と評価に役立ちます。画像診断技術の革新が進むにつれ、新しい造影剤の開発が後押しされています。しかし、造影剤の潜在的な副作用による患者の安全性への懸念の高まりが、造影剤の採用を妨げています。高度な造影剤製造手順の統合と、画像処理手順における優れた性能を提供するナノ粒子の新たな浸透は、造影剤市場の拡大に有益な機会を記載しています。

主要市場の統計
基準年[2023年] 36億7,000万米ドル
予測年[2024年] 40億2,000万米ドル
予測年[2030年] 70億4,000万米ドル
CAGR(%) 9.75%

タイプ:正確な診断モダリティの需要により、ヨード系造影剤の使用が増加

バリウムベースの造影剤は主に胃、腸、食道などの消化管(GI)画像診断に使用されます。これらの化合物は、試験部位に応じて経口摂取または直腸投与されます。ガドリニウム系造影剤は消化管の内壁を被覆し、潰瘍、ポリープ、腫瘍などの異常を強調することにより、消化管の詳細な画像を効果的に記載しています。ガドリニウム系造影剤は、主に磁気共鳴画像法(MRI)で使用され、画像の鮮明さと細部を強調します。これらの造影剤は、さまざまな身体部位の血管、炎症、腫瘍、腫瘍の血管の可視性を向上させる。ガドリニウムは、神経、筋骨格系、心臓血管系の画像診断において特に有益です。ヨード系薬剤は、コンピュータ断層撮影(CT)スキャン、血管造影、静脈造影に広く使用されています。これらの薬剤は通常静脈注射され、X線を周囲の組織とは異なる方法で吸収または散乱させることにより、血管内の異なる身体構造または体液間のコントラストを増強する能力で知られています。ヨード化造影剤は、血管の可視化、腫瘍の同定、内科的・外科的治療計画の立案に有用です。マイクロバブル造影剤は、体内の血液や体液のコントラストを強調するために超音波画像診断で使用される特別に設計された薬剤です。気体を充填したマイクロバブルは静脈内に注入され、特に心臓や血管の画像診断に有用です。マイクロバブル造影剤により、血流の可視化、心臓の機能、肝臓やその他の臓器の異常の検出が可能になります。

用途:インターベンショナルラジオロジーにおける造影剤の高い採用率

インターベンショナルカーディオロジーにおける造影剤は、カテーテルを使用した手技において、心臓血管の解剖学的構造と病理学の視覚化を強化するために極めて重要です。これらのメディアは冠動脈の明瞭な描出を可能にし、冠動脈疾患の診断や病変の重症度評価を容易にします。また、ステント留置やバルーン血管形成術のガイドとして、インターベンショナル・カーディオロジストの判断材料となる画像をリアルタイムで提供するために不可欠です。インターベンショナル・ラジオロジーでは、画像ガイダンスのもとで行われる低侵襲手技において、造影剤が臓器、血管、組織の可視性を高めます。このような用途には、造影剤により腫瘍の血管解剖学的構造を明確にし、標的治療に役立てる腫瘍塞栓術、造影剤により拡大が必要な狭窄血管を描出する血管形成術、様々な静脈構造の鑑別を可能にする静脈サンプリングなどが含まれます。放射線学では、造影剤はレントゲン写真、CTスキャン、MRI画像の強調に重要であり、異なる身体部位間のコントラストを向上させ、病気や状態の診断に役立ちます。CTスキャンでは、ヨウ素化造影剤は血管の輪郭を描き、腹部や骨盤部、脳などの関心領域を強調し、感染症、炎症性疾患、がん、血管疾患などを効果的に診断します。MRI試験では、ガドリニウムベースの造影剤が異常組織と正常組織のコントラストを高めるために使用され、神経学的な脳の状態、筋骨格系の異常、腫瘍の評価などの詳細な評価に非常に有用です。

地域別洞察

南北アメリカ、特に米国とカナダでは、先進医療画像技術の採用率が高いです。米国は医療技術革新の中心地であり、副作用の低減と画像の鮮明度向上を目指した新規製剤に関する特許が急増しています。カナダの造影剤市場は、確立された医療システムと画像診断の研究を促進する政府のイニシアチブの恩恵を受けています。アメリカ諸国の顧客の購買行動は、品質と安全性を重視し、早期診断の利点に対する高い意識に影響されています。アジア太平洋、特に中国、日本、インドは、造影剤の著しい成長市場として浮上しています。医療インフラの増加、病気の早期診断に関する意識、高齢化人口の増加が、アジア太平洋における造影剤の需要を牽引しています。中国では、造影剤の安全性と有効性を高めることを目的とした最近の特許が、同国の研究開発への取り組みを浮き彫りにしています。日本は強固な医療システムで知られ、革新的な画像技術を優先しているため、先進的な造影剤の使用を後押ししています。インドの造影剤市場は、医療への投資が増加し、診断サービスを強化するための官民パートナーシップ(PPP)に注目が集まっていることが特徴です。欧州、中東、アフリカ(欧州・中東・アフリカ)地域では、欧州諸国がハイエンド技術による画像診断サービスの強化に注力しており、多様な様相を呈しています。同地域では、患者の安全性とともに環境の持続可能性に対する意識の高まりを反映し、メディアの生産と使用とは対照的に、より環境に優しい慣行を積極的に取り入れています。医療インフラが急成長している中東では、医療施設への投資や研究・イノベーションの重視により、造影剤に対する需要が高まっています。アフリカの造影剤市場は、未開拓市場、医療費の増加、非侵襲的診断法に対する意識の高まりにより、拡大の可能性を秘めています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは造影剤市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、造影剤市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発とイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.造影剤市場の市場規模と予測は?

2.造影剤市場の予測期間中に投資を検討すべき製品、用途は何か?

3.造影剤市場の技術動向と規制枠組みは?

4.造影剤市場における主要ベンダーの市場シェアは?

5.造影剤市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • がんや心血管疾患の罹患率の上昇
      • 高度な画像技術に対する消費者の嗜好の高まり
      • 医療インフラへの投資の急増
    • 抑制要因
      • より安全で効果的な造影剤の研究開発にかかる高コスト
    • 機会
      • 新しい造影剤の革新と開発の増加
      • イメージング手技において優れた性能を発揮するナノ粒子の開発が進む
    • 課題
      • 造影剤に対する潜在的な副作用による患者の安全性への懸念の高まり
  • 市場セグメンテーション分析
    • タイプ:正確な診断法の需要によりヨウ素化造影剤の使用が増加
    • 用途:インターベンショナルラジオロジーにおける造影剤の高い採用率
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 造影剤市場:タイプ別

  • イントロダクション
  • バリウムベース造影剤
  • ガドリニウムベース造影剤
  • ヨウ素化造影剤
  • マイクロバブル造影剤

第7章 造影剤市場:手技別

  • イントロダクション
  • 磁気共鳴画像
  • 超音波
  • X線とコンピューター断層撮影

第8章 造影剤市場:投与経路別

  • イントロダクション
  • 血管内投与
  • 経口投与
  • 直腸経路

第9章 造影剤市場:用途別

  • イントロダクション
  • インターベンショナル心臓病学
  • インターベンショナルラジオロジー
  • 放射線科

第10章 造影剤市場:エンドユーザー別

  • イントロダクション
  • 外来手術センター
  • 画像診断センター
  • 病院・クリニック

第11章 造影剤市場:適応疾患別

  • イントロダクション
  • がん
  • 心血管疾患
  • 胃腸障害
  • 筋骨格障害
  • 腎臓疾患
  • 神経学的障害

第12章 南北アメリカの造影剤市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第13章 アジア太平洋の造影剤市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第14章 欧州・中東・アフリカの造影剤市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第15章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析
  • 戦略分析と提言

第16章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. CONTRAST MEDIA MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRAST MEDIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTRAST MEDIA MARKET DYNAMICS
  • FIGURE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 28. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRAST MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & COMPUTED TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & COMPUTED TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RADIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. CHINA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 176. CHINA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. INDIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 188. INDIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. INDONESIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 200. INDONESIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. JAPAN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. JAPAN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 236. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. TAIWAN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 272. TAIWAN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. THAILAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. THAILAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. VIETNAM CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. VIETNAM CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 321. DENMARK CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 322. DENMARK CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. EGYPT CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. EGYPT CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. EGYPT CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 334. EGYPT CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. FINLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 338. FINLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 339. FINLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 340. FINLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 341. FINLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. FINLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. FINLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 344. FINLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 345. FINLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 346. FINLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 347. FRANCE CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 348. FRANCE CONTRAST MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 349. FRANCE CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2023 (USD MILLION)
  • TABLE 350. FRANCE CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2024-2030 (USD MILLION)
  • TABLE 351. FRANCE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 352. FRANCE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 353. FRANCE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 354. FRANCE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 355. FRANCE CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 356. FRANCE CONTRAST MEDIA MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 357. FRANCE CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 358. FRANCE CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 359. GERMANY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. GERMANY CONTRAST MEDIA MARKE
目次
Product Code: MRR-434CCDA04E9E

[190 Pages Report] The Contrast Media Market size was estimated at USD 3.67 billion in 2023 and expected to reach USD 4.02 billion in 2024, at a CAGR 9.75% to reach USD 7.04 billion by 2030.

Contrast media are substances used in medical imaging to enhance the visibility of tissues, organs, and other structures inside the body. They work by altering how imaging tools, such as computed tomography (CT), X-rays, ultrasound scans, and magnetic resonance imaging (MRI), interact with the body. By improving the contrast of the images obtained, these agents help provide a clearer picture of the area being examined, aiding in the accurate diagnosis and assessment of various conditions. The increasing innovations in imaging technologies are boosting the development of new contrast agents. However, the rising patient safety concerns due to potential adverse reactions to contrast agents hinder the adoption of contrast media. Integration of advanced contrast media manufacturing procedures and the emerging penetration of nanoparticles offering superior performance in imaging procedures offer remunerative opportunities for the expansion of the contrast media market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.67 billion
Estimated Year [2024] USD 4.02 billion
Forecast Year [2030] USD 7.04 billion
CAGR (%) 9.75%

Type: Rising use of iodinated contrast media owing to the demand for accurate diagnostic modalities

Barium-based contrast media are primarily used in gastrointestinal (GI) imaging, including stomach, intestines, and esophagus exams. These compounds are ingested orally or administered rectally, depending on the area of interest. They effectively provide detailed images of the GI tract by coating the lining and highlighting abnormalities such as ulcers, polyps, or tumors. Gadolinium-based contrast agents are primarily utilized in Magnetic Resonance Imaging (MRI) to enhance the clarity and detail of the images. These agents improve the visibility of blood vessels, inflammation, tumors, and the vascularity of tumors in various body parts. Gadolinium is particularly beneficial in neurological, musculoskeletal, and cardiovascular imaging. Iodinated contrast media are widely used in computed tomography (CT) scans, angiography, and venography. These agents are typically injected intravenously and are known for their ability to enhance the contrast between different body structures or fluids within vessels by absorbing or scattering X-rays differently than surrounding tissues. Iodinated contrast media are invaluable in visualizing blood vessels, identifying tumors, and planning medical or surgical treatment. Microbubble contrast media are specially designed agents used in ultrasound imaging to enhance the contrast of blood or fluids within the body. These gas-filled microbubbles are injected intravenously and are particularly useful in cardiac and vascular imaging. Microbubble contrast media enable the visualization of blood flow, the function of the heart, and the detection of abnormalities in the liver and other organs.

Application: High adoption of contrast media in interventional radiology

Contrast media in interventional cardiology are pivotal for enhancing the visualization of cardiovascular anatomy and pathology during catheter-based procedures. These media allow for the clear delineation of coronary arteries, facilitating the diagnosis of coronary artery disease and assessing lesion severity. They are indispensable in guiding stent placement or balloon angioplasty by providing real-time images that inform the interventional cardiologist's decisions. In interventional radiology, contrast media enhances the visibility of organs, blood vessels, and tissues during minimally invasive procedures conducted under image guidance. These applications include tumor embolization, where the contrast helps define the vascular anatomy of tumors for targeted treatment; vascular angioplasty, with contrast media delineating narrowed vessels needing dilation; and venous sampling, which enables the differentiation of various venous structures. In radiology, contrast media are crucial in enhancing radiographs, CT scans, and MRI images, improving the contrast between different body parts to help diagnose diseases and conditions. In CT scans, iodinated contrast media outline blood vessels and highlight areas of interest in the abdominal and pelvic region, brain, and more, effectively diagnosing infections, inflammatory conditions, cancers, and vascular diseases. In MRI scans, gadolinium-based contrast agents are employed to increase the contrast between abnormal and normal tissue, making them invaluable in the detailed evaluation of neurological brain conditions, musculoskeletal anomalies, and assessment of tumors.

Regional Insights

In the Americas, particularly in the United States and Canada, there is a high adoption rate of advanced medical imaging technologies. The United States, being a hub for medical innovation, has seen a surge in patents related to novel contrast media formulations aiming for reduced side effects and improved imaging clarity. The contrast media market in Canada benefits from a well-established healthcare system and government initiatives promoting research in diagnostic imaging. Customer purchasing behavior in American countries is influenced by a strong emphasis on quality and safety and a high level of awareness about the benefits of early diagnosis. The Asia Pacific region, particularly China, Japan, and India, is emerging as a significantly growing market for contrast media. The increasing healthcare infrastructure, awareness regarding early disease diagnosis, and a growing aging population drive the demand for contrast media in the Asia-Pacific region. In China, recent patents aimed at enhancing the safety and efficacy of contrast agents highlight the country's commitment to research and development. Japan, known for its robust healthcare system, prioritizes innovative imaging technologies, thereby boosting the use of advanced contrast media. In India, the contrast media market is characterized by increasing investment in healthcare and a growing focus on public-private partnerships (PPPs) to enhance diagnostic services. In the EMEA region, Europe exhibits a diverse landscape, with EU countries focusing on enhancing imaging services through high-end technologies. The region actively embraces greener practices in contrast to media production and usage, reflecting a growing consciousness towards environmental sustainability alongside patient safety. The Middle East, amid its burgeoning healthcare infrastructure, shows a growing demand for contrast media driven by investments in healthcare facilities and a growing emphasis on research and innovation. The contrast media market in Africa presents potential for expansion owing to its untapped markets, increasing healthcare expenditure, and rising awareness about non-invasive diagnostic methods.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Contrast Media Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contrast Media Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Contrast Media Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Spa, Covis Group, Daiichi Sankyo Co. Ltd., Fuji Pharma Co. Ltd., GE Healthcare Co., Ltd., Guerbet SA, iMAX Diagnostic Imaging Limited, J. B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus Medical Imaging, Inc., M.Biotech Limited, Miltenyi Biotec B.V. & Co. KG, Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd., nanoPET Pharma GmbH, SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, and Vitalquan, LLC.

Market Segmentation & Coverage

This research report categorizes the Contrast Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Barium-Based Contrast Media
    • Gadolinium-Based Contrast Media
    • Iodinated Contrast Media
    • Microbubble Contrast Media
  • Procedure
    • Magnetic Resonance Imaging
    • Ultrasound
    • X-ray & Computed Tomography
  • Route Of Administration
    • Intravascular Route
    • Oral Route
    • Rectal Route
  • Application
    • Interventional Cardiology
    • Interventional Radiology
    • Radiology
  • End-user
    • Ambulatory Surgery Centers
    • Diagnostic Imaging Centers
    • Hospitals & Clinics
  • Disease Indication
    • Cancer
    • Cardiovascular Disorders
    • Gastrointestinal Disorders
    • Musculoskeletal Disorders
    • Nephrological Disorders
    • Neurological Disorders
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Contrast Media Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contrast Media Market?

3. What are the technology trends and regulatory frameworks in the Contrast Media Market?

4. What is the market share of the leading vendors in the Contrast Media Market?

5. Which modes and strategic moves are suitable for entering the Contrast Media Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer and cardiovascular diseases
      • 5.1.1.2. Increasing consumer preference toward advanced imaging technologies
      • 5.1.1.3. Burgeoning investment in healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with research and development of safer and more effective contrast agents
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing innovations and development of new contrast agents
      • 5.1.3.2. Growing development of nanoparticles offering superior performance in imaging procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Rising patient safety concerns due to potential adverse reactions to contrast agents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising use of iodinated contrast media owing to the demand for accurate diagnostic modalities
    • 5.2.2. Application: High adoption of contrast media in interventional radiology
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Contrast Media Market, by Type

  • 6.1. Introduction
  • 6.2. Barium-Based Contrast Media
  • 6.3. Gadolinium-Based Contrast Media
  • 6.4. Iodinated Contrast Media
  • 6.5. Microbubble Contrast Media

7. Contrast Media Market, by Procedure

  • 7.1. Introduction
  • 7.2. Magnetic Resonance Imaging
  • 7.3. Ultrasound
  • 7.4. X-ray & Computed Tomography

8. Contrast Media Market, by Route Of Administration

  • 8.1. Introduction
  • 8.2. Intravascular Route
  • 8.3. Oral Route
  • 8.4. Rectal Route

9. Contrast Media Market, by Application

  • 9.1. Introduction
  • 9.2. Interventional Cardiology
  • 9.3. Interventional Radiology
  • 9.4. Radiology

10. Contrast Media Market, by End-user

  • 10.1. Introduction
  • 10.2. Ambulatory Surgery Centers
  • 10.3. Diagnostic Imaging Centers
  • 10.4. Hospitals & Clinics

11. Contrast Media Market, by Disease Indication

  • 11.1. Introduction
  • 11.2. Cancer
  • 11.3. Cardiovascular Disorders
  • 11.4. Gastrointestinal Disorders
  • 11.5. Musculoskeletal Disorders
  • 11.6. Nephrological Disorders
  • 11.7. Neurological Disorders

12. Americas Contrast Media Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Contrast Media Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Contrast Media Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Fresenius Kabi Debuts New Generic MRI Contrast Agent
    • 15.3.2. Imagion Expands Collaboration With Siemens On MRI Contrast Agent
    • 15.3.3. GE HealthCare Expands Contrast Media Portfolio with Launch of MRI Agent Pixxoscan (gadobutrol)
  • 15.4. Strategy Analysis & Recommendation

16. Competitive Portfolio

  • 16.1. Key Company Profiles
  • 16.2. Key Product Portfolio